Jul 30, 2014 at 08:58 | Source: CNBC-TV18
Here are top 10 stocks to focus on July 30 - L&T, ITC, GMR Infra, Unitech, Bharti Airtel, Ranbaxy, Escorts, VIP, IDFC and Spicejet.
Jul 30, 2014 at 08:26 | Source: CNBC-TV18
ITC | Bharti Airtel | Larsen and Toubro | Sesa Sterlite | Ranbaxy Labs | Torrent Power | Dr Reddy's Labs | Tata Steel | Petronet LNG | Tata Global | State Bank Of Mysore | Aditya Birla Money | Inox Leisure | Prism Cement | VIP Industries | IDFC | Indiabulls Power and Akzo Nobel India are stocks, which are in the news today.
Jul 30, 2014 at 08:12 | Source: Moneycontrol.com
Wall Street lost its initial gains to close lower after US announced fresh sanctions against Russia. In Europe, shares closed higher on Tuesday, as investors reacted to corporate earnings. Meanwhile, Asia is positive in morning trade.
Jul 29, 2014 at 17:14 | Source: CNBC-TV18
Consolidated revenue of the company fell 9.6 percent on yearly basis to Rs 2,426.2 crore due to lower exports (declined over 13 percent) while domestic revenue increased by 11.8 percent to Rs 621.6 crore in the quarter gone by.
Jul 28, 2014 at 18:15 | Source: CNBC-TV18
Analysts feel operating profit (EBITDA) may be impacted due to consent decree costs that is expected to be in single digits. They expect mark-to-market gains during the quarter but higher tax rate and weak operational performance may pull down adjusted profit.
Jul 28, 2014 at 12:14 | Source: CNBC-TV18
Hemant Thukral of Aditya Birla Money is of the view that Ranbaxy Laboratories may test Rs 610-615 and feels that one should exit around Rs 600-610.
Jul 28, 2014 at 11:02 | Source: CNBC-TV18
In an interview with CNBC-TV18, Hemant Thukral of Aditya Birla Money shares his outlook on stock specific bets and where the market is headed hereon.
Jul 28, 2014 at 08:19 | Source: CNBC-TV18
Kunal Saraogi of Equityrush advises selling Tata Power Company with a target of Rs 96 and State Bank of India (SBI) with a target of Rs 2400.
Jul 25, 2014 at 21:22 | Source: CNBC-TV18
The pressure is building up on the Indian drug regulator to clampdown on the fake drugs that are inundating the Indian market. A desperate CDSCO has decided to restart an old scheme -- reward to any whistleblower who is instrumental in the seizure of counterfeit drugs and cosmetics.
Jul 25, 2014 at 11:23 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Dr Reddy's Laboratories, Glenmark Pharma, Shasun Pharmaceuticals and Ranbaxy Laboratories will be getting astrological support.